Search

everythinglearnresearchcommunity

for

Search:↓

COVID-19 diagnosis is linked to new or worsening hair diseases, with stress from the pandemic likely contributing.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

The most effective way to diagnose non-scarring hair loss is by transverse sectioning, and some cases, particularly in males with inflammation around hair follicles, might be curable.

COVID-19 and vaccines cause various skin reactions and highlight the need for dermatologists in managing these issues and addressing vaccine distribution disparities.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Many people in Saudi Arabia experienced hair loss after COVID-19, especially women, those treated with antivirals, and those with a history of hair shedding.

Androgenetic alopecia causes hair thinning due to increased androgen activity, treatable with minoxidil and finasteride.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

Some vitamins and minerals are important for preventing hair loss, but treating hair loss with them without a known deficiency is not proven effective.

Hair loss is a frequent long-term effect of COVID-19, and oral minoxidil is the most common effective treatment.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

Many young men with hair loss have low levels of vitamin D and B12.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Hair loss can cause stress and mental health issues, so treatments should address both the physical and psychological aspects, involving a team of dermatologists, psychologists, and hair specialists.

The document concludes that hair loss and acne in women can be due to both androgen-related and unrelated causes, requiring a collaborative treatment approach.

Psychological stress and personal history are significant factors in hair loss.

COVID-19 can cause various skin issues, from mild rashes to severe conditions.

Light-based therapy can help regrow hair in different types of hair loss, but more research is needed.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Mental health and hair loss are linked, and treating both can improve well-being.

Vitamin D deficiency is common in children with non-scarring alopecia, and managing it may help treatment.

Trichoscopy is effective for diagnosing hair and scalp disorders without invasive biopsies.

Topical treatments like minoxidil and corticosteroids are effective for hair loss, with JAK inhibitors promising for alopecia areata.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

About 61% of women who had COVID-19 experienced hair loss afterward.

Some treatments for hair loss, like finasteride, biotin, and minoxidil, can be effective, but their success varies by individual case.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.